The anti-inflammatory and organ protective effect of Teprenone
Not Applicable
- Conditions
- perioperative patient(malignant tumor, rheumatism, maitenance dyalisis, administration of steroids are excluded)
- Registration Number
- JPRN-UMIN000011401
- Lead Sponsor
- Fukushima Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
maintenance hemodyalisis, malignant tumor, administration of steroids, rheumatism
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum CRP, WBC, AST, ALT, BUN, Crea, IL-6, IL-8 and TNF-alpha of blood sample in pre operation, post operation, 1,3 and 6th day after operation.
- Secondary Outcome Measures
Name Time Method